找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Diabetes Complications, Comorbidities and Related Disorders; Enzo Bonora,Ralph A. DeFronzo Reference work 20181st edition Springer Interna

[復(fù)制鏈接]
樓主: Forbidding
31#
發(fā)表于 2025-3-26 22:15:15 | 只看該作者
https://doi.org/10.1007/978-3-319-44433-8acute metabolic complications; cancer; cardiovascular disease; chronic diabetic complications; pregnancy
32#
發(fā)表于 2025-3-27 04:10:31 | 只看該作者
33#
發(fā)表于 2025-3-27 06:01:15 | 只看該作者
34#
發(fā)表于 2025-3-27 12:07:46 | 只看該作者
35#
發(fā)表于 2025-3-27 14:40:52 | 只看該作者
36#
發(fā)表于 2025-3-27 21:44:51 | 只看該作者
Vladimir O. Rukavishnikov,Michael Pughion, with dyslipidemia contributing when present. In T2DM, although the aforementioned complications of diabetes may each contribute to increased ASCVD, the dyslipidemia plays a more important role. Optimal glycemic control with diabetes medications can normalize plasma lipid levels in most individu
37#
發(fā)表于 2025-3-28 01:04:45 | 只看該作者
Vladimir O. Rukavishnikov,Michael Pugh dyslipidemia, elevated blood pressure, elevated plasma glucose, a prothrombotic state, and a pro-inflammatory state. The presence of the metabolic syndrome doubles the risk for ASCVD and causes a fivefold increase in the risk for type 2 diabetes. Multiple factors contribute to the syndrome. The mos
38#
發(fā)表于 2025-3-28 06:05:02 | 只看該作者
Giuseppe Caforio,Marina Nuciariost cases there is a genetic predisposition to develop hypertension in people with diabetes compounded by the presence of obesity and high sodium intake. While reduction in weight and sodium intake ameliorates elevations in blood pressure in most cases medications are needed. With proper control of
39#
發(fā)表于 2025-3-28 07:21:37 | 只看該作者
Social Research and the Military by impairing physiologic vascular repair. Furthermore, hyperglycaemia often associates with obesity, hypertension, and dyslipidaemia in the cluster of metabolic syndrome. This results in an accelerated atherosclerosis, leading to a very high risk of cardiovascular events and mortality. A multifacto
40#
發(fā)表于 2025-3-28 10:43:40 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-31 13:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
呼图壁县| 浦江县| 榆树市| 呼伦贝尔市| 昭通市| 永康市| 句容市| 富蕴县| 南召县| 阿坝| 奉新县| 盘锦市| 浙江省| 信宜市| 阜南县| 东丽区| 泊头市| 临潭县| 台州市| 墨玉县| 化德县| 濮阳县| 武平县| 芦溪县| 满洲里市| 华容县| 崇州市| 巴马| 宣威市| 中超| 抚顺县| 宁阳县| 探索| 巨鹿县| 峡江县| 兴文县| 汕尾市| 长葛市| 广州市| 当雄县| 磐石市|